|
1.
Share Success: Letters From Readers
Letter
I: From Joanna B.
Received
at Testimonial Submit Form Sunday, July 22, 2018 at 15:26:11
(Unedited)
Hi, my name is Joanna.
Joanna thanked Ezorb for helping me improve my health.
Osteoporosis has so improved that I rarely feel the same pain as ever. Osteoporosis has slipped into osteopenia. My last bone density showed me good results. Has any further improvement been able to continue with Ezorb?
Sincerely,
Joanna B.
Letter II: From Linda L.
Received
at Customer Service Thursday, April 26, 2018 3:42 PM
(Unedited)
I am a hairstylist at a busy salon, and I have many customers who are already ordering this product because of me. They have seen me in pain and walking weird for over a year until I started taking EZorb, which my husband found out about while researching bone-spurs on the internet.
This product is really amazing, and I know I can sell it because I am living proof that it works. My co-workers and clients have already asked me how I am walking better before I have mentioned anything!
I have given over 20 people the name of your product and company name to order it on their own! If I have some to sell them on-the spot (we sell many different products at the salon) after they see my improvement, it would be even better.
Many of my clients are older and don't trust the internet or don't really know how to use computers, websites or how to order over the internet, but they would definitely buy EZorb from me directly.
Some of these older ladies need this more than some people, as you know. I am actually amazed at how it has helped me. So not only can they see for themselves what it has done for me, I can give true testimonial. Thanks!
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Bariatric Surgery May Reduce Vascular Events In Diabetes Patients
An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.
And another study in the same journal addresses the issue of which definition of weight regain is most closely associated with progression of diabetes and deterioration in quality of life.
The first study, from David Arterburn (Kaiser Permanente Washington Health Research Institute, Seattle, USA) and colleagues, compared outcomes of 5301 obese people with type 2 diabetes who had undergone surgery (mostly Roux-en-Y gastric bypass) with those of 14,934 people, matched for age, sex, study site, BMI, glycated hemoglobin level, and insulin use, who had not undergone surgery.
Over a median follow-up of 4.7 and 4.6 years, respectively, macrovascular outcomes (coronary heart disease or cerebrovascular disease) were significantly less frequent in patients who underwent surgery than those who did not. The 5-year cumulative event rates were 2.1% versus 4.3% for macrovascular outcomes and 1.3% versus 4.5% for mortality (the latter being an exploratory post-hoc analysis).
After further adjustment for variables such as ethnicity, diabetes duration, and medication use, this equated to a significant reduction of 40% for macrovascular events and 67% for mortality with bariatric surgery. There was a significant reduction in the risk for coronary events and a nonsignificant reduction in that of cerebrovascular events, of which there were fewer.
Although the findings are based on observational data, the researchers' sensitivity analysis indicated that the protective effect of surgery could be explained by unmeasured confounding only if the confounders had an effect far larger than any known risk factors, such as hypertension.
It is therefore "implausible that an unmeasured confounder exists that can overcome the effect of bariatric surgery observed in the current analysis study," they say, although they stress that the benefits should be confirmed by randomized trials.
The second study, by Wendy King (University of Pittsburgh, Pennsylvania, USA) and co-researchers, drew on data from 1406 patients (around a third with diabetes) who underwent Roux-en-Y gastric bypass and had at least 5 years of follow-up in the prospective LABS-2 study.
At their lowest post-surgery bodyweight, the participants had lost a median 37.4% of their presurgery bodyweight and their median BMI was 28.8 kg/m2. At the most recent assessment, these were a corresponding 28.0% and 33.2 kg/m2.
The team looked at five measures of weight regain: kg regained; change in BMI; percentage of presurgery weight; percentage of lowest achieved weight; and percentage of maximum weight lost. All of these measures significantly correlated with progression of diabetes, satisfaction with surgery, and physical health-related quality of life, and most correlated with mental health-related quality of life.
But the strongest associations were seen for weight regain as a percentage of maximum weight lost, with each 18.9% increase associated with a 51% increased risk for diabetes deterioration and 28%, 11%, and 56% increases in the risk for a clinically important deterioration in physical and mental health-related quality of life and satisfaction with surgery, respectively.
In a linked editorial, Amir Ghaferi and Oliver Varban (both from University of Michigan, Ann Arbor, USA) say that the study "highlights the importance of setting appropriate expectations about weight loss and comorbidity resolution after bariatric surgery and also reinforces the concept that obesity is a chronic disease demanding long-term multidisciplinary care."
They add that "the weight regain and return of comorbidity highlights the need for careful follow-up and counseling of these patients and early intervention when weight regain occurs" and call for improved cooperation and communication between surgical and primary care providers to achieve this.
Original article appeared in 10-16-2018 | Metabolic surgery | News.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
